Literature DB >> 2186180

The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines.

O K Haffar1, G R Nakamura, P W Berman.   

Abstract

Mutagenesis of the transmembrane domain and cytoplasmic tail of human immunodeficiency virus type 1 envelope glycoprotein gp160 revealed that its intracellular transport and processing in transfected cell lines were modulated by a functional domain included in the carboxy-terminal sequence consisting of residues 751 to 856.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2186180      PMCID： PMC249502     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  27 in total

1.  Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein.

Authors:  R M Venable; R W Pastor; B R Brooks; F W Carson
Journal:  AIDS Res Hum Retroviruses       Date:  1989-02       Impact factor: 2.205

2.  Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.

Authors:  D Dowbenko; G Nakamura; C Fennie; C Shimasaki; L Riddle; R Harris; T Gregory; L Lasky
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin.

Authors:  R Pal; R C Gallo; M G Sarngadharan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  The structure of melittin in the form I crystals and its implication for melittin's lytic and surface activities.

Authors:  T C Terwilliger; L Weissman; D Eisenberg
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

6.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  DNA sequence analysis of the type-common glycoprotein-D genes of herpes simplex virus types 1 and 2.

Authors:  L A Lasky; D J Dowbenko
Journal:  DNA       Date:  1984

8.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.

Authors:  M J Zoller; M Smith
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

9.  Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes.

Authors:  O K Haffar; D J Dowbenko; P W Berman
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

10.  Dissection of the Golgi complex. I. Monensin inhibits the transport of viral membrane proteins from medial to trans Golgi cisternae in baby hamster kidney cells infected with Semliki Forest virus.

Authors:  G Griffiths; P Quinn; G Warren
Journal:  J Cell Biol       Date:  1983-03       Impact factor: 10.539
View more
  19 in total

1.  Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

Authors:  S S Chen; S F Lee; C T Wang
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.

Authors:  A Bültmann; W Muranyi; B Seed; J Haas
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  D H Gabuzda; A Lever; E Terwilliger; J Sodroski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.

Authors:  M J Mulligan; G V Yamshchikov; G D Ritter; F Gao; M J Jin; C D Nail; C P Spies; B H Hahn; R W Compans
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin.

Authors:  Y Morikawa; E Barsov; I Jones
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Mapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity.

Authors:  R Talbott; G Kraus; D Looney; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.

Authors:  Daniel P Leaman; Heather Kinkead; Michael B Zwick
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.

Authors:  G D Ritter; G Yamshchikov; S J Cohen; M J Mulligan
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  C D Weiss; J M White
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 10.  HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.